Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 82 are a HOLD (32.16%), 157 are a BUY (61.57%), 16 are a SELL (6.27%).
Analyst Salveen Richter works at GOLDMAN SACHS with a stock forecast success ratio of 62.64% fulfilled within 249.39 days on average. Previously, Salveen Richter worked at GOLDMAN.
Salveen Richter’s has documented 514 price targets and ratings displayed on 49 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on DNLI, Denali Therapeutics at 29-Feb-2024.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.41 (50.69%)
29
1 months 1 days ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$13.41 (80.83%)
40
1 months 13 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$22.41 (135.08%)
40
1 months 29 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$16.41 (98.92%)
33
1 months 29 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$19.41 (117.00%)
1 months 29 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Salveen Richter is most bullish on?
Which stock is Salveen Richter is most reserved on?
What Year was the first public recommendation made by Salveen Richter?